Antibe Therapeutics Inc. (ATBPF)
USD 0.22
(0.0%)
USD 0.22
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -20.44 Million CAD | 23.68% |
| 2022 | -25.14 Million CAD | -5.97% |
| 2021 | -23.73 Million CAD | -42.57% |
| 2020 | -17.97 Million CAD | -41.78% |
| 2019 | -11.83 Million CAD | -87.26% |
| 2018 | -6.14 Million CAD | -29.21% |
| 2017 | -4.92 Million CAD | -60.94% |
| 2016 | -2.98 Million CAD | 31.49% |
| 2015 | -4.4 Million CAD | -65.15% |
| 2014 | -2.66 Million CAD | -161.59% |
| 2013 | -1.01 Million CAD | -8.13% |
| 2012 | -942.13 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -4.98 Million CAD | 13.49% |
| 2024 Q3 | -4.59 Million CAD | 15.85% |
| 2024 Q1 | -5.79 Million CAD | -79.24% |
| 2023 Q3 | -4.2 Million CAD | 32.07% |
| 2023 Q4 | -3.22 Million CAD | 23.22% |
| 2023 Q2 | -6.18 Million CAD | -10.98% |
| 2023 Q1 | -5.57 Million CAD | -5.43% |
| 2023 FY | - CAD | 23.68% |
| 2022 Q4 | -5.28 Million CAD | -2.5% |
| 2022 Q2 | -8.29 Million CAD | -34.36% |
| 2022 Q1 | -6.17 Million CAD | -14.46% |
| 2022 FY | - CAD | -5.97% |
| 2022 Q3 | -5.15 Million CAD | 37.8% |
| 2021 Q1 | -4.77 Million CAD | 3.71% |
| 2021 FY | - CAD | -42.57% |
| 2021 Q3 | -5.82 Million CAD | 24.96% |
| 2021 Q4 | -5.39 Million CAD | 7.4% |
| 2021 Q2 | -7.76 Million CAD | -62.64% |
| 2020 Q2 | -4.67 Million CAD | -55.19% |
| 2020 Q3 | -3.99 Million CAD | 14.52% |
| 2020 Q4 | -4.95 Million CAD | -23.99% |
| 2020 FY | - CAD | -41.78% |
| 2020 Q1 | -3.01 Million CAD | 29.03% |
| 2019 Q3 | -3.09 Million CAD | -46.9% |
| 2019 Q4 | -4.24 Million CAD | -37.24% |
| 2019 FY | - CAD | -87.26% |
| 2019 Q1 | -2.39 Million CAD | -34.85% |
| 2019 Q2 | -2.1 Million CAD | 11.91% |
| 2018 Q1 | -1.56 Million CAD | 13.06% |
| 2018 FY | - CAD | -29.21% |
| 2018 Q4 | -1.77 Million CAD | -37.17% |
| 2018 Q3 | -1.29 Million CAD | 21.16% |
| 2018 Q2 | -1.63 Million CAD | -4.73% |
| 2017 Q2 | -893.01 Thousand CAD | -6.11% |
| 2017 FY | - CAD | -60.94% |
| 2017 Q4 | -1.8 Million CAD | -36.68% |
| 2017 Q3 | -1.31 Million CAD | -47.51% |
| 2017 Q1 | -841.62 Thousand CAD | 40.39% |
| 2016 Q2 | -757.09 Thousand CAD | -99.05% |
| 2016 FY | - CAD | 31.49% |
| 2016 Q4 | -1.41 Million CAD | -201.02% |
| 2016 Q3 | -469.06 Thousand CAD | 38.04% |
| 2016 Q1 | -380.35 Thousand CAD | 41.37% |
| 2015 FY | - CAD | -65.15% |
| 2015 Q2 | -1.27 Million CAD | 20.28% |
| 2015 Q1 | -1.6 Million CAD | -82.65% |
| 2015 Q4 | -648.79 Thousand CAD | 26.0% |
| 2015 Q3 | -876.73 Thousand CAD | 31.27% |
| 2014 Q2 | -544.14 Thousand CAD | -84.04% |
| 2014 FY | - CAD | -161.59% |
| 2014 Q4 | -876.05 Thousand CAD | 7.69% |
| 2014 Q3 | -949.04 Thousand CAD | -74.41% |
| 2014 Q1 | -295.66 Thousand CAD | -15.78% |
| 2013 FY | - CAD | -8.13% |
| 2013 Q4 | -255.35 Thousand CAD | 26.7% |
| 2013 Q3 | -348.37 Thousand CAD | -51.56% |
| 2013 Q2 | -229.86 Thousand CAD | -24.14% |
| 2013 Q1 | -185.15 Thousand CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AVITA Medical, Inc. | -39.56 Million USD | 48.324% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -1656.615% |
| Össur hf. | 137.38 Million USD | 114.883% |
| QHSLab, Inc. | -91.29 Thousand USD | -22297.117% |
| Wellstar International, Inc. | -1.35 Million USD | -1407.315% |
| Össur hf. | 137.38 Million USD | 114.883% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | -58.46 Thousand USD | -34875.454% |
| Aurora Spine Corporation | -454.37 Thousand USD | -4399.998% |
| BrainsWay Ltd. | -2.31 Million USD | -784.768% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -7354.519% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 470.308% |
| Vivos Inc. | -2.79 Million USD | -632.042% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -10242.909% |
| REMSleep Holdings, Inc. | -1.66 Million USD | -1125.432% |
| Zecotek Photonics Inc. | -3.44 Million USD | -494.006% |
| Avitar, Inc. | -1.66 Million USD | -1125.984% |
| Nanomix Corporation | -8.13 Million USD | -151.199% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 309.196% |
| Theraclion SA | -2.05 Million USD | -897.032% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | -1.45 Million USD | -1308.049% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | -1087.478% |
| Lombard Medical, Inc. | -28.06 Million USD | 27.152% |
| ALR Technologies Inc. | -6.4 Million USD | -219.469% |
| Stratec SE | 39.91 Million USD | 151.228% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 20355.986% |
| Heart Tronics, Inc. | -14.85 Million USD | -37.627% |
| MicroPort Scientific Corporation | -347.57 Million USD | 94.117% |
| VMS Rehab Systems, Inc. | -68.55 USD | -29827762.874% |
| NewCardio, Inc. | -9.37 Million USD | -118.001% |
| Guided Therapeutics, Inc. | -3.12 Million USD | -554.095% |
| Ingen Technologies, Inc. | -8639.00 USD | -236582.486% |
| Odyssey Group International, Inc. | -2.13 Million USD | -856.328% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -5296.325% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -2791.956% |
| SANUWAVE Health, Inc. | -9.15 Million USD | -123.416% |
| IR-Med Inc. | -4.89 Million USD | -317.968% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | -54.005% |
| Polarean Imaging plc | -11.19 Million USD | -82.644% |
| United American Healthcare Corporation | -59 Thousand USD | -34555.932% |
| ECGI Holdings, Inc. | -2.99 Million USD | -583.747% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -17190.016% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -3149.77% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -3877.822% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 4583.401% |
| Urologix, Inc. | -6.34 Million USD | -222.305% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -1549.802% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -2569.436% |
| SS Innovations International, Inc. | -20.37 Million USD | -0.348% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -9076.548% |
| Smith & Nephew plc | 1 Billion USD | 102.039% |
| NIOX Group Plc | 11.07 Million USD | 284.621% |
| Fuse Medical, Inc. | 1.83 Million USD | 1214.086% |
| Broncus Holding Corporation | -25.19 Million USD | 18.857% |
| Brain Scientific Inc. | -7.93 Million USD | -157.723% |
| Pressure BioSciences, Inc. | -9.39 Million USD | -117.732% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -111025.0% |